Computer-Aided Diagnosis in Multiparametric MRI of the Prostate: An Open-Access Online Tool for Lesion Classification with High Accuracy.

artificial intelligence computer-aided diagnosis machine learning prostate cancer prostate mpMRI

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
21 Aug 2020
Historique:
received: 12 07 2020
revised: 09 08 2020
accepted: 20 08 2020
entrez: 23 8 2020
pubmed: 23 8 2020
medline: 23 8 2020
Statut: epublish

Résumé

Computer-aided diagnosis (CADx) approaches could help to objectify reporting on prostate mpMRI, but their use in many cases is hampered due to common-built algorithms that are not publicly available. The aim of this study was to develop an open-access CADx algorithm with high accuracy for classification of suspicious lesions in mpMRI of the prostate. This retrospective study was approved by the local ethics commission, with waiver of informed consent. A total of 124 patients with 195 reported lesions were included. All patients received mpMRI of the prostate between 2014 and 2017, and transrectal ultrasound (TRUS)-guided and targeted biopsy within a time period of 30 days. Histopathology of the biopsy cores served as a standard of reference. Acquired imaging parameters included the size of the lesion, signal intensity (T2w images), diffusion restriction, prostate volume, and several dynamic parameters along with the clinical parameters patient age and serum PSA level. Inter-reader agreement of the imaging parameters was assessed by calculating intraclass correlation coefficients. The dataset was stratified into a train set and test set (156 and 39 lesions in 100 and 24 patients, respectively). Using the above parameters, a CADx based on an Extreme Gradient Boosting algorithm was developed on the train set, and tested on the test set. Performance optimization was focused on maximizing the area under the Receiver Operating Characteristic curve (ROC

Identifiants

pubmed: 32825612
pii: cancers12092366
doi: 10.3390/cancers12092366
pmc: PMC7565879
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : CRC 1181 - project Z02

Références

J Magn Reson Imaging. 2013 May;37(5):1035-54
pubmed: 23606141
Eur Urol. 2013 Sep;64(3):448-55
pubmed: 23751135
Histopathology. 2019 Jan;74(1):135-145
pubmed: 30565298
J Magn Reson Imaging. 2009 Aug;30(2):327-34
pubmed: 19629981
Lancet Oncol. 2019 Jan;20(1):100-109
pubmed: 30470502
AJR Am J Roentgenol. 2020 Jul 29;:
pubmed: 32755220
Curr Opin Biomed Eng. 2017 Sep;3:20-27
pubmed: 29732440
Comput Biol Med. 2015 May;60:8-31
pubmed: 25747341
Turk J Urol. 2018 May;44(3):189-194
pubmed: 29733790
Int J Comput Assist Radiol Surg. 2016 Apr;11(4):657-66
pubmed: 26337442
Asian J Androl. 2013 Mar;15(2):249-53
pubmed: 23353717
Radiology. 2013 Jun;267(3):787-96
pubmed: 23392430
JAMA. 2015 Jan 27;313(4):390-7
pubmed: 25626035
Proc SPIE Int Soc Opt Eng. 2011 Mar 4;7963:79630U
pubmed: 25301991
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Eur Urol. 2016 Jan;69(1):16-40
pubmed: 26427566
J Can Chiropr Assoc. 2011 Jun;55(2):69-75
pubmed: 21629460
Radiology. 2016 Sep;280(3):793-804
pubmed: 27035179
Eur Radiol. 2017 Dec;27(12):5204-5214
pubmed: 28656462
Eur J Radiol. 2019 Dec;121:108704
pubmed: 31669798
Bone. 2019 Mar;120:254-261
pubmed: 30445200
Eur Urol. 2016 Jan;69(1):41-9
pubmed: 26361169
Insights Imaging. 2018 Jun;9(3):325-335
pubmed: 29616496
Transl Androl Urol. 2018 Feb;7(1):132-144
pubmed: 29594027
Biomed Res Int. 2014;2014:789561
pubmed: 25525604
Eur Urol. 2019 Sep;76(3):340-351
pubmed: 30898406
IEEE Trans Med Imaging. 2014 May;33(5):1083-92
pubmed: 24770913
Eur Radiol. 2013 Aug;23(8):2051-60
pubmed: 23579418
Eur Urol. 2017 Aug;72(2):177-188
pubmed: 28196723
J Magn Reson Imaging. 2009 Jul;30(1):161-8
pubmed: 19557732
Radiology. 2011 Oct;261(1):46-66
pubmed: 21931141
Phys Med Biol. 2012 Jun 21;57(12):3833-51
pubmed: 22640958

Auteurs

Stephan Ellmann (S)

Department of Radiology, University Hospital Erlangen, 91054 Erlangen, Germany.

Michael Schlicht (M)

Department of Radiology, University Hospital Erlangen, 91054 Erlangen, Germany.

Matthias Dietzel (M)

Department of Radiology, University Hospital Erlangen, 91054 Erlangen, Germany.

Rolf Janka (R)

Department of Radiology, University Hospital Erlangen, 91054 Erlangen, Germany.

Matthias Hammon (M)

Department of Radiology, University Hospital Erlangen, 91054 Erlangen, Germany.

Marc Saake (M)

Department of Radiology, University Hospital Erlangen, 91054 Erlangen, Germany.

Thomas Ganslandt (T)

Department of Medical Informatics, Friedrich-Alexander-University Erlangen-Nuremberg, 91058 Erlangen, Germany.
Heinrich-Lanz-Center for Digital Health, Department of Biomedical Informatics, University Medicine Mannheim, Heidelberg University, 68177 Mannheim, Germany.

Arndt Hartmann (A)

Institute of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany.

Frank Kunath (F)

Department of Urology and Paediatric Urology, University Hospital Erlangen, 91054 Erlangen, Germany.

Bernd Wullich (B)

Department of Urology and Paediatric Urology, University Hospital Erlangen, 91054 Erlangen, Germany.

Michael Uder (M)

Department of Radiology, University Hospital Erlangen, 91054 Erlangen, Germany.

Tobias Bäuerle (T)

Department of Radiology, University Hospital Erlangen, 91054 Erlangen, Germany.

Classifications MeSH